Method for decreasing capillary permeability in the retina

Details for Australian Patent Application No. 2002301863 (hide)

Owner Novartis AG

Inventors Campochiaro, Peter Anthony; Kane, Frances Elizabeth; Green, Kenneth E; Brazzell, Romulus Kimbro

Agent Davies Collison Cave

Pub. Number AU-B-2002301863

Priority 60337691 08.11.01 US

Filing date 6 November 2002

Wipo publication date 12 June 2003

Acceptance publication date 20 January 2005

International Classifications

A61K 031/553 - having at least one nitrogen and at least one oxygen as ring hetero atoms, e.g. loxapine, staurosporine

A61P 009/10 Drugs for disorders of the cardiovascular system

Event Publications

28 November 2002 Complete Application Filed

  Priority application(s): 60337691 08.11.01 US

12 June 2003 Application Open to Public Inspection

  Published as AU-B-2002301863

20 January 2005 Application Accepted

  Published as AU-B-2002301863

19 May 2005 Standard Patent Sealed

4 June 2009 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This patent ceased under section 143(a), or Expired. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2002301864-Drug-releasing trabecular implant for glaucoma treatment

2002301862-A Storage Device for an Elongated Flexible Article or Articles